[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 115,415
  • Shares Outstanding, K 11,119
  • Annual Sales, $ 385,790 K
  • Annual Income, $ -18,670 K
  • EBIT $ -16 M
  • EBITDA $ -3 M
  • 60-Month Beta 0.65
  • Price/Sales 0.30
  • Price/Cash Flow 24.72
  • Price/Book 0.58

Options Overview Details

View History
  • Implied Volatility 44.38% (+3.15%)
  • Historical Volatility 32.42%
  • IV Percentile 24%
  • IV Rank 15.99%
  • IV High 176.01% on 03/26/26
  • IV Low 19.32% on 05/19/26
  • Expected Move (DTE 31) 0.92 (8.73%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 232
  • Volume Avg (30-Day) 480
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 20,852
  • Open Int (30-Day) 24,448
  • Expected Range 9.60 to 11.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.68
  • Number of Estimates 1
  • High Estimate $-0.68
  • Low Estimate $-0.68
  • Prior Year $0.04
  • Growth Rate Est. (year over year) -1,800.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.78 +7.57%
on 06/25/26
11.57 -9.08%
on 06/22/26
-0.52 (-4.71%)
since 06/18/26
3-Month
9.78 +7.57%
on 06/25/26
13.43 -21.67%
on 05/05/26
-0.53 (-4.80%)
since 04/21/26
52-Week
9.22 +14.10%
on 03/13/26
15.37 -31.55%
on 07/23/25
-3.27 (-23.71%)
since 07/21/25

Most Recent Stories

More News
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended...

MED : 10.52 (+1.35%)
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System

The leading health and wellness company unveils an evolutionary transformation from weight loss to optimal metabolic health, powered by breakthrough science and human connection

MED : 10.52 (+1.35%)
3 Unpopular Stocks That Concern Us

3 Unpopular Stocks That Concern Us

TDC : 29.33 (-4.15%)
IHRT : 3.74 (-5.32%)
MED : 10.52 (+1.35%)
A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack

A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack

MED : 10.52 (+1.35%)
1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds

1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds

TPL : 418.91 (+3.21%)
ACVA : 7.93 (+7.02%)
MED : 10.52 (+1.35%)
3 Reasons MED is Risky and 1 Stock to Buy Instead

3 Reasons MED is Risky and 1 Stock to Buy Instead

MED : 10.52 (+1.35%)
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer

Johnson will succeed Dan Chard as CEO; Chard to remain Chairman of the Board

MED : 10.52 (+1.35%)
Medifast (NYSE:MED) Delivers Impressive Q1 CY2026

Medifast (NYSE:MED) Delivers Impressive Q1 CY2026

MED : 10.52 (+1.35%)
Medifast: Q1 Earnings Snapshot

Medifast: Q1 Earnings Snapshot

MED : 10.52 (+1.35%)
Medifast Announces First Quarter 2026 Financial Results

Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the first quarter ended March 31, 2026. ...

MED : 10.52 (+1.35%)

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 10.87
2nd Resistance Point 10.70
1st Resistance Point 10.61
Last Price 10.52
1st Support Level 10.35
2nd Support Level 10.18
3rd Support Level 10.09

See More

52-Week High 15.37
Fibonacci 61.8% 13.02
Fibonacci 50% 12.30
Fibonacci 38.2% 11.57
Last Price 10.52
52-Week Low 9.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.